Skip to main content
. 2020 Oct 20;174:106197. doi: 10.1016/j.rmed.2020.106197

Table 2.

Laboratory findings.

Reference values Admission day (n = 33) Follow up (n = 33)
Hematology
- White blood cells, × 109/L 4.0–10.0 6.9 {5.1–7.9} 6.5 {5.6–7.4}
- Hemoglobin, g/dl m: 14.0-18.0 13.9 {11.8–14.9} 13.6 {11.7–14.5}
w: 12.0-16.0
- Platelets, × 109/L 150–400 205 {164–241} 262 {202–303}
- Lymphocytes, % 22.0–53.0 11.9 {9.4–21.0} 26.7 {20.6–33.8}
- Eosinophils, %
1.0–6.0
0.1 {0–0.2}
2.1 {1.4–3.0}
Coagulation
- INR 1.2 {1.1–1,2} 1 {0.9–1.2}
- aPTT, sec. 25.1–36.5 27.2 {25.2–29.3} 29.0 {27.8–31.4}
- Antithrombin III, % 80–120 107 {96–114}
- Fibrinogen, mg/dl 238–498 342 {293–391}
- D-dimer, ng/ml < 500 855 {739–873} 474 {323–675}
- Thrombin time, sec.
10–17
21 {17.4–24.5}
15 {14-16}
Clinical Chemistry
- HbA1c, % < 5.7 5.9 {5.5–6.8} 5.3 {5.0–6.1}
- Sodium, mmol/l 136–145 138 {136–141} 141 {139–143}
- Potassium, mmol/l 3.6–5.5 4.2 {3.8–4.7} 4.5 {4.3–4.7}
- Phosphate, mmol/l 0.81–1.45 0.97 {0.85–1.12}
- Cholesterol, mg/dl < 200 145 {116–195} 177 {135–231}
- HDL-cholesterol, mg/dl > 45 35 {30-40} 50 {45–55}
- LDL-cholesterol, mg/dl < 130 86 {66–140} 118 {77–161}
- Triglycerides, mg/dl < 200 109 {93–189} 140 {107–196}
- Lipoprotein (a), nmol/l < 75 23 {9-32}
- Albumin, g/dl 3.5–5.2 3.8 {3.5–4.2} 4.3 {4.1–4.6}
- Bilirubin (total), mg/dl < 1.2 0.6 {0.5–0.6} 0.43 {0.29–0.67}
- AST, U/l < 35 48 {32–60} 24 {20-29}
- ALT, U/l < 35 29 {22-40} 24 {17-39}
- Gamma-GT, U/l < 40 29 {22–84} 30 {17–46}
- AP, U/l 35–105 64 {50–82} 74 {56–85}
- LDH, U/l m: 135-225 324 {258–438} 213 {196–227}
w: 135-214
- CK, U/l m: < 174 129 {82–337} 84 {49–109}
w: < 140
- CK-MB-Mass, U/l < 26 U/l 2 {1.5–3.0}
- hs-Troponin T, pg/ml < 14.0 21 {9–140} 8 {4-21}
- NT-proBNP, pg/ml < 220 147 {27–710} 183 {43–474}
- Urea, mg/dl 16.6–48.5 32 {23-42} 36 {28–47}
- Creatinine, mg/dl 0.5–1.2 1 {0.8–1.1} 0.88 {0.79–1.13}
- CRP, mg/l < 5 57.1 {20.9–103.1} 2.0 {1.1–7.9}
- Procalcitonin, ng/ml
< 0.5
0.1 {0.1–0.2}
0.05 {0.04–0.06}
Iron metabolism
- Iron, μg/dl 33–193 79.3 {60.5–99.1}
- Transferrin saturation, % 16.0–45.0 20.4 {15.3–26.5}
- Ferritin, ng/ml
15.0–150.0
1140.5 {955–1196.8}
154.6 {81.8–362.8}
Proteins
- Cystatin C, mg/l 0.61–0.95 1.03 {0.96–1.42}
- Myoglobin, μg/l
25–58
34 {34-34}
27 {21–55}
Thyroid parameters
- TSH, mU/l 0.27–4.20 1.5 {1.1–1.8} 1.6 {1.1–2.2}
- fT3, ng/l 2.0–4.4 1.8 {1.7–2.4} 3.2 {2.7–3.4}
- fT4, ng/dl
0.9–1.7
1.2 {1.1–1.4}
1.1 {1.1–1.2}
Cytokines
- sIL-2-receptor, U/ml 158–623 470 {401–602}
- IL-6, pg/ml < 7.0 64.2 {38.5–106.9} 2.4 {1.5–3.9}
- TNF alpha, pg/ml < 8.1 8.1 {5.8–9.8}

Values are median {interquartile range}.

ABBREVIATIONS: ALP = alkaline phosphatase; ALT = alanine transaminase; aPTT = activated partial thromboplastin time; AST = aspartate transaminase; CK = creatine kinase; CKmb = creatine kinase myocardial band; CRP = C-reactive protein; FT3 = unbound triiodothyronine; FT4 = unbound thyroxine; Gamma-GT = gamma-glutamyltransferase; HbA1c = glycated hemoglobin; HDL = high-density lipoprotein; hs-Troponin-T = high sensitive Troponin-T; IL-6 = interleukin-6; INR = international normalized ratio; LDH = lactate dehydrogenase; LDL = low-density lipoprotein; NT-proBNP = N-terminal pro B-type natriuretic peptide; sIL 2 = soluble interleukin‐2 receptor; TNF = tumor necrosis factor; TSH = thyroid-stimulating hormone.